{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:20:32Z","timestamp":1780453232137,"version":"3.54.1"},"publisher-location":"Chichester, UK","reference-count":132,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd008394.pub2","type":"reference-entry","created":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T00:35:34Z","timestamp":1352421334000},"source":"Crossref","is-referenced-by-count":6,"title":["Interventions for treating leg ulcers in people with sickle cell disease"],"prefix":"10.1002","author":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M","family":"Knight-Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Martinez-Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,11,14]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD008394.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0035-9203(87)90049-6","article-title":"Topical antibiotics in chronic sickle cell leg ulcers","volume":"81","author":"Baum","year":"1987","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD008394.pub2-BIB2|cit2","first-page":"46","article-title":"Topical antibiotics in chronic sickle-cell leg ulcers","volume":"35 Suppl","author":"Macfarlane","year":"1986","journal-title":"West Indian Medical Journal"},{"key":"10.1002\/14651858.CD008394.pub2-BIB3|cit3","unstructured":"La Grenade L Thomas PW Serjeant GR A randomized controlled trial of solcoseryl and duoderm in chronic sickle-cell ulcers West Indian Medical Journal 1993 121 3"},{"key":"10.1002\/14651858.CD008394.pub2-BIB4|cit4","series-title":"The National Sickle Cell Disease Program Annual Meeting Conference Proceedings","first-page":"175a","article-title":"Arginine butyrate in sickle cell leg ulcers: interim findings of a phase II trial [abstract]","author":"Koshy","year":"2000"},{"key":"10.1002\/14651858.CD008394.pub2-BIB5|cit5","series-title":"The National Sickle Cell Disease Program Annual Meeting Conference Proceedings","first-page":"Abstract no: 12","article-title":"Arginine butyrate in sickle cell leg ulcers: interim findings of a randomized phase II trial [abstract]","author":"Koshy","year":"2001"},{"key":"10.1002\/14651858.CD008394.pub2-BIB6|cit6","first-page":"417a","article-title":"Arginine butyrate in sickle cell leg ulcers: interim findings of a phase II trial [abstract]","volume":"Suppl","author":"Koshy","year":"1999","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD008394.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2010.08395.x","article-title":"A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers","volume":"151","author":"McMahon","year":"2010","journal-title":"British Journal of Haematology"},{"issue":"11 Pt 1 of 2","key":"10.1002\/14651858.CD008394.pub2-BIB8|cit8","first-page":"10a","article-title":"A phase II trial of arginine butyrate in refractory sickle cell leg ulcers [abstract]","volume":"100\u00a0","author":"McMahon","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD008394.pub2-BIB9|cit9","first-page":"164","article-title":"Isoxsuprine hydrochloride in the therapy of sickle cell leg ulceration","volume":"26","author":"Serjeant","year":"1977","journal-title":"West Indian Medical Journal"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD008394.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0190-9622(97)70156-7","article-title":"Propionyl-L-carnitine in chronic leg ulcers of homozygous sickle cell disease: a pilot study","volume":"37","author":"Serjeant","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB11|cit11","series-title":"The National Sickle Cell Disease Program Annual Meeting Conference Proceedings","article-title":"Accelerated healing of chronic sickle cell leg ulcers treated with a RGD matrix","author":"Ramirez","year":"1994"},{"issue":"6","key":"10.1002\/14651858.CD008394.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1182\/blood.V84.6.1775.1775","article-title":"Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study Group","volume":"84","author":"Wethers","year":"1994","journal-title":"Blood"},{"key":"10.1002\/14651858.CD008394.pub2-BIB13|cit13","doi-asserted-by":"crossref","unstructured":"Afifi AM Adnan M Taha M Amasha ME Xanthinol nicotinate in the management of leg ulcers associated with haemoglobinopathies Current Medical Research and Opinion 1979 309 13","DOI":"10.1185\/03007997909109443"},{"issue":"6","key":"10.1002\/14651858.CD008394.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-111-6-534","article-title":"Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta thalassemia: a pilot study","volume":"111","author":"Cacciola","year":"1990","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008394.pub2-BIB15|cit15","first-page":"45","article-title":"InGaP (670nm) laser use in the leg ulcer healing in patients with sickle cell anemia","volume":"52","author":"Lucena","year":"2007","journal-title":"Anais da Faculdade de Medicina da Universidade Federal de Pernambuco"},{"issue":"2","key":"10.1002\/14651858.CD008394.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1590\/S1516-84842010005000033","article-title":"Evaluation of the topical application of opioid analgesia for a leg ulcer of a sickle cell disease patient","volume":"32","author":"Neves","year":"2010","journal-title":"Revista Brasileira de Hematologia e Hemoterapia"},{"issue":"3","key":"10.1002\/14651858.CD008394.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/1117-1936.175137","article-title":"Efficacy of natural honey in the healing of leg ulcers in sickle cell anaemia","volume":"11","author":"Okany","year":"2004","journal-title":"The Nigerian Postgraduate Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD008394.pub2-BIB18|cit18","first-page":"62","article-title":"Negative pressure therapy for complex wounds in patients with sickle-cell disease: a case study","volume":"56","author":"Paggiaro","year":"2010","journal-title":"Ostomy Wound Management"},{"key":"10.1002\/14651858.CD008394.pub2-BIB19|cit19","doi-asserted-by":"crossref","unstructured":"Sawyer PN Haque S Reddy K Sophie Z Feller J Wound healing effects of debrisan on varicose, postoperative, decubitus, and sickle-cell ulcers in man Vascular Surgery 1979 251 6","DOI":"10.1177\/153857447901300405"},{"key":"10.1002\/14651858.CD008394.pub2-BIB20|cit20","doi-asserted-by":"crossref","unstructured":"Serjeant GR Galloway RE Gueri MC Oral zinc sulphate in sickle-cell ulcers Lancet 1970 891 2","DOI":"10.1016\/S0140-6736(70)92067-2"},{"issue":"3","key":"10.1002\/14651858.CD008394.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jcp.22195","article-title":"Sickle cell anemia and vascular dysfunction: the nitric oxide connection","volume":"224","author":"Akinsheye","year":"2010","journal-title":"Journal of Cellular Physiology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB22|cit22","first-page":"87","article-title":"Leg ulceration in sickle cell disease in Nigeria","volume":"31","author":"Akinyanju","year":"1979","journal-title":"Tropical and Geographical Medicine"},{"key":"10.1002\/14651858.CD008394.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000204799","article-title":"Recombinant human erythropoietin induced rapid healing of a chronic leg ulcer in a patient with sickle cell disease","volume":"86","author":"al-Momen","year":"1991","journal-title":"Acta Haematologica"},{"key":"10.1002\/14651858.CD008394.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2141.2004.05025.x","article-title":"Are there clinical phenotypes of homozygous sickle cell disease?","volume":"126","author":"Alexander","year":"2004","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ajh.20063","article-title":"Topical GM-CSF hastens healing of leg ulcers in sickle cell disease","volume":"76","author":"Alikhan","year":"2004","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00007611-197702000-00033","article-title":"Social effects of leg ulceration in sickle cell anemia","volume":"70","author":"Alleyne","year":"1977","journal-title":"Southern Medical Journal"},{"key":"10.1002\/14651858.CD008394.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1468-3083.2006.02003.x","article-title":"Rapid healing of long-lasting sickle cell leg ulcer treated with allogeneic keratinocytes","volume":"21","author":"Amini-Adle","year":"2007","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB28|cit28","first-page":"366","article-title":"Sickle cell leg ulcers in Ghana","volume":"69","author":"Ankra-Badu","year":"1992","journal-title":"East African Medical Journal"},{"issue":"15","key":"10.1002\/14651858.CD008394.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2012.466","article-title":"Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective","volume":"307","author":"Anonymous","year":"2012","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD008394.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.freeradbiomed.2007.08.014","article-title":"Redox-dependent impairment of vascular function in sickle cell disease","volume":"43","author":"Aslan","year":"2007","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1002\/14651858.CD008394.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1477-7525-7-75","article-title":"Utility of WHOQOL-BREF in measuring quality of life in sickle cell disease","volume":"7","author":"Asnani","year":"2009","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1002\/14651858.CD008394.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1182\/blood.V99.3.1096","article-title":"Treatment of painful sickle cell leg ulcers with topical opioids","volume":"99","author":"Ballas","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD008394.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajh.21550","article-title":"Definitions of the phenotypic manifestations of sickle cell disease","volume":"85","author":"Ballas","year":"2010","journal-title":"American Journal of Hematology"},{"issue":"4","key":"10.1002\/14651858.CD008394.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/jcp.2008.058867","article-title":"Neonatal screening for sickle cell disease in France","volume":"62","author":"Bardakdjian-Michau","year":"2009","journal-title":"Journal of Clinical Pathology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB36|cit36","volume-title":"A dictionary of food and nutrition","author":"Bender","year":"2009"},{"issue":"1","key":"10.1002\/14651858.CD008394.pub2-BIB37|cit37","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005082.pub2","article-title":"Silver based wound dressings and topical agents for treating diabetic foot ulcers","author":"Bergin","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008394.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-111-6-534","article-title":"Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta thalassemia: a pilot study","volume":"111","author":"Cacciola","year":"1989","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD008394.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood.V75.12.2467b.2467b","article-title":"Blood hypercoagulability as a risk factor for leg ulcers in sickle cell disease","volume":"75","author":"Cacciola","year":"1990","journal-title":"Blood"},{"key":"10.1002\/14651858.CD008394.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1024\/0301-1526.30.4.277","article-title":"Impaired venous hemodynamics in a minority of patients with chronic leg ulcers due to sickle cell anemia","volume":"30","author":"Chalchal","year":"2001","journal-title":"VASA. Zeitschrift f\u00fcr Gef\u00e4sskrankheiten. Journal for Vascular Diseases"},{"key":"10.1002\/14651858.CD008394.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1365-2141.2002.03833.x","article-title":"Chronic leg ulceration in homozygous sickle cell disease: the role of venous incompetence","volume":"119","author":"Clare","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1745-6215-8-39","article-title":"Standardising outcomes for clinical trials and systematic reviews","volume":"8","author":"Clarke","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD008394.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/jwh.2007.CDC4","article-title":"Sickle cell disease: current activities, public health implications, and future directions","volume":"16","author":"Creary","year":"2007","journal-title":"Journal of Women's Health"},{"key":"10.1002\/14651858.CD008394.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2141.2008.07115.x","article-title":"Venous incompetence, poverty and lactate dehydrogenase in Jamaica are important predictors of leg ulceration in sickle cell anaemia","volume":"142","author":"Cumming","year":"2008","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1590\/S0102-311X2002000300032","article-title":"Neonatal screening for hemoglobinopathies: a pilot study in Porto Alegre, Rio Grande do Sul, Brazil","volume":"18","author":"Daudt","year":"2002","journal-title":"Cadernos de Sa\u00fade P\u00fablica"},{"key":"10.1002\/14651858.CD008394.pub2-BIB46|cit46","first-page":"11","article-title":"Chronic leg ulcers in sickle cell disease: experience in Ibadan, Nigeria","volume":"20","author":"Durosinmi","year":"1991","journal-title":"African Journal of Medicine and Medical Sciencies"},{"key":"10.1002\/14651858.CD008394.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0889-8588(05)70404-4","article-title":"Leg ulcers in sickle cell disease","volume":"10","author":"Eckman","year":"1996","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"4","key":"10.1002\/14651858.CD008394.pub2-BIB48|cit48","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003556","article-title":"Debridement of diabetic foot ulcers","author":"Edwards","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008394.pub2-BIB49|cit49","first-page":"28","article-title":"Hyperbaric oxygen in the treatment of malleolar ulcer from sickle cell anemia","volume":"8","author":"Espinosa Mart\u00ednez","year":"1992","journal-title":"Revista Cubana de Hematolog\u00eda, Inmunolog\u00eda y Hemoterapia"},{"key":"10.1002\/14651858.CD008394.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-4362.1990.tb04768.x","article-title":"Treatment of sickle cell leg ulcers with pentoxifylline","volume":"29","author":"Frost","year":"1990","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB51|cit51","doi-asserted-by":"crossref","unstructured":"Gabriel SE Normand SL Getting the Methods Right - The Foundation of Patient-Centered Outcomes Research The New England Journal of Medicine 2012 Epub ahead of print","DOI":"10.1056\/NEJMp1207437"},{"key":"10.1002\/14651858.CD008394.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7547\/87507315-93-3-240","article-title":"Human skin equivalent in the treatment of chronic leg ulcers in sickle cell disease patients","volume":"93","author":"Gordon","year":"2003","journal-title":"Journal of the American Podiatry Association"},{"key":"10.1002\/14651858.CD008394.pub2-BIB53|cit53","unstructured":"Brozek J Oxman A Sch\u00fcnemann H GRADEpro 2008"},{"key":"10.1002\/14651858.CD008394.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1258\/096914106777589650","article-title":"Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels","volume":"13","author":"Gulbis","year":"2006","journal-title":"Journal of Medical Screening"},{"issue":"12","key":"10.1002\/14651858.CD008394.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence--imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD008394.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence--inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD008394.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence--publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD008394.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence--indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD008394.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD008394.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD008394.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD008394.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD008394.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB64|cit64","first-page":"Epub print","article-title":"GRADE guidelines 11-making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"Apr 27","author":"Guyatt","year":"2012","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2141.2008.07097.x","article-title":"Advances in clinical research in sickle cell disease","volume":"141","author":"Hagar","year":"2008","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2133.2007.08323.x","article-title":"Sickle cell leg ulcers: a\u00a0frequently disabling complication and a marker of severity","volume":"158","author":"Halabi-Tawil","year":"2008","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-113-5-412_1","article-title":"L-carnitine for leg ulcers","volume":"113","author":"Harrell","year":"1990","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008394.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2141.2003.04775.x","article-title":"Neonatal screening for sickle cell disorders","volume":"124","author":"Henthorn","year":"2004","journal-title":"British Journal of Haematology"},{"issue":"7414","key":"10.1002\/14651858.CD008394.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008394.pub2-BIB70|cit70","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions The Cochrane Collaboration. Available from www.cochrane-handbook.org 2011"},{"key":"10.1002\/14651858.CD008394.pub2-BIB71|cit71","unstructured":"Higgins JPT Altman DG (editors) Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011) The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD008394.pub2-BIB72|cit72","unstructured":"Higgins JPT Deeks JJ Altman DG on behalf of the CSMG Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD008394.pub2-BIB73|cit73","doi-asserted-by":"crossref","unstructured":"Hopewell S Clarke M Higgins JPT (editors) Core reporting of outcomes in effectiveness trials Cochrane Methods. Cochrane DB Syst Rev 2010 1 29","DOI":"10.1002\/14651858.CD201001"},{"issue":"10","key":"10.1002\/14651858.CD008394.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"3-4","key":"10.1002\/14651858.CD008394.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jrsm.19","article-title":"Meta-research: The art of getting it wrong","volume":"1","author":"Ioannidis","year":"2010","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD008394.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato","year":"2007","journal-title":"Blood Reviews"},{"key":"10.1002\/14651858.CD008394.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions","volume":"84","author":"Kato","year":"2009","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008394.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/00034983.1983.11811730","article-title":"Sickle cell disease in Sierra Leone: a clinical and haematological analysis in older children and adults","volume":"77","author":"Knox-Macaulay","year":"1983","journal-title":"Annals of Tropical Medicine and Parasitology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood.V74.4.1403.1403","article-title":"Leg ulcers in patients with sickle cell disease","volume":"74","author":"Koshy","year":"1989","journal-title":"Blood"},{"key":"10.1002\/14651858.CD008394.pub2-BIB81|cit81","first-page":"121","article-title":"A randomized controlled trial of solcoseryl and duoderm in chronic sickle-cell ulcers","volume":"42","author":"Grenade","year":"1993","journal-title":"West Indian Medical Journal"},{"key":"10.1002\/14651858.CD008394.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1365-2141.2008.07206.x","article-title":"Efficacy of the endothelin receptor blocker bosentan for refractory sickle cell leg ulcers","volume":"142","author":"Lionnet","year":"2008","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0035-9203(86)90137-9","article-title":"Bacteriology of sickle cell leg ulcers","volume":"80","author":"MacFarlane","year":"1986","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD008394.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.biocel.2006.01.010","article-title":"Sickle cell disease and nitric oxide: a paradigm shift?","volume":"38","author":"Mack","year":"2006","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/136485907X154638","article-title":"Sickle cell disease in Africa: burden and research priorities","volume":"101","author":"Makani","year":"2007","journal-title":"Annals of Tropical Medicine and Parasitology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB86|cit86","volume-title":"Concise Medical Dictionary","author":"Martin","year":"2011"},{"key":"10.1002\/14651858.CD008394.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jcp.2008.058834","article-title":"Neonatal haemoglobinopathy screening in Spain","volume":"62","author":"Ma\u00f1\u00fa Pereira","year":"2009","journal-title":"Journal of Clinical Pathology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000076487","article-title":"Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers","volume":"208","author":"Mery","year":"2004","journal-title":"Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD008394.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ajh.21838","article-title":"Leg ulcers in sickle cell disease","volume":"85","author":"Minniti","year":"2010","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD008394.pub2-BIB91|cit91","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/cs0920153","article-title":"Postural vasoconstriction and leg ulceration in homozygous sickle cell disease","volume":"92","author":"Mohan","year":"1997","journal-title":"Clinical Science"},{"key":"10.1002\/14651858.CD008394.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/CS20000004","article-title":"Abnormal venous function in patients with homozygous sickle cell (SS) disease and chronic leg ulcers","volume":"98","author":"Mohan","year":"2000","journal-title":"Clinical Science"},{"key":"10.1002\/14651858.CD008394.pub2-BIB93|cit93","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD008394.pub2-BIB94|cit94","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004983.pub2","article-title":"Wound cleansing for pressure ulcers","author":"Moore","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008394.pub2-BIB95|cit95","first-page":"51","article-title":"Immunity and leg ulcers in homozygous sickle cell disease","volume":"6","author":"Morgan","year":"1981","journal-title":"Journal of Clinical & Laboratory Immunology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB96|cit96","doi-asserted-by":"crossref","unstructured":"Morris CR Mechanisms of vasculopathy in sickle cell disease and thalassemia Hematology \/ the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2008 177 85","DOI":"10.1182\/asheducation-2008.1.177"},{"key":"10.1002\/14651858.CD008394.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-60761-803-4_13","article-title":"Diagnosis and management of sickle cell disorders","volume":"663","author":"Mousa","year":"2010","journal-title":"Methods in Molecular Biology"},{"issue":"10","key":"10.1002\/14651858.CD008394.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00017","article-title":"Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting","volume":"140","author":"Nebeker","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008394.pub2-BIB99|cit99","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002303","article-title":"Compression for preventing recurrence of venous ulcers","author":"Nelson","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD008394.pub2-BIB100|cit100","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2141.2006.06074.x","article-title":"Sickle Cell Leg Ulcers: Associations with Haemolysis and SNPs in Klotho, TEK and Genes of the TGF-beta\/BMP Pathway","volume":"133","author":"Nolan","year":"2006","journal-title":"British Journal of Haematology"},{"issue":"21","key":"10.1002\/14651858.CD008394.pub2-BIB101|cit101","first-page":"1","article-title":"Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration","volume":"4","author":"O'Meara","year":"2000","journal-title":"Health Technology Assessment"},{"issue":"1","key":"10.1002\/14651858.CD008394.pub2-BIB102|cit102","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000265.pub2","article-title":"Compression for venous leg ulcers","author":"O'Meara","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008394.pub2-BIB103|cit103","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003557.pub3","article-title":"Antibiotics and antiseptics for venous leg ulcers","author":"O'Meara","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008394.pub2-BIB104|cit104","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archderm.1987.01660280084029","article-title":"Sickle cell leg ulcers are associated with HLA-B35 and Cw4","volume":"123","author":"Ofosu","year":"1987","journal-title":"Archives of Dermatology"},{"issue":"5989","key":"10.1002\/14651858.CD008394.pub2-BIB105|cit105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1194035","article-title":"Medicine. Sickle cell disease at 100 years","volume":"329","author":"Orkin","year":"2010","journal-title":"Science (New York, N.Y.)"},{"key":"10.1002\/14651858.CD008394.pub2-BIB106|cit106","first-page":"288","article-title":"Leg ulcers in sickle cell disease","volume":"29","author":"Paladino","year":"2007","journal-title":"Revista Brasileira de Hematologia e Hemoterapia"},{"issue":"3","key":"10.1002\/14651858.CD008394.pub2-BIB107|cit107","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001103.pub2","article-title":"Dressings for healing venous leg ulcers","author":"Palfreyman","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008394.pub2-BIB108|cit108","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(95)90629-0","article-title":"Molgramostim to treat SS-sickle cell leg ulcers","volume":"345","author":"Pieters","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008394.pub2-BIB109|cit109","doi-asserted-by":"crossref","DOI":"10.1590\/S1135-57272008000400008","volume-title":"Dictionary of Epidemiology","author":"Porta","year":"2008"},{"issue":"5","key":"10.1002\/14651858.CD008394.pub2-BIB110|cit110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ajh.21676","article-title":"Sickle cell disease in the United States: looking back and forward at 100 years of progress in management and survival","volume":"85","author":"Prabhakar","year":"2010","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB111|cit111","first-page":"307","article-title":"Sickle cell syndromes and ulcer of inferior extremities","volume":"60","author":"Ramalho","year":"1985","journal-title":"Anais Brasileiros de Dermatologia"},{"issue":"9757","key":"10.1002\/14651858.CD008394.pub2-BIB112|cit112","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008394.pub2-BIB113|cit113","first-page":"866","article-title":"Rapid healing of sickle cell leg ulcers treated with collagen dressing","volume":"81","author":"Reindorf","year":"1989","journal-title":"Journal of the National Medical Association"},{"key":"10.1002\/14651858.CD008394.pub2-BIB114|cit114","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/archderm.1953.01540110098016","article-title":"Healing of chronic sicklemia leg ulcers healed by cortisone","volume":"68","author":"Rice","year":"1953","journal-title":"A.M.A. Archives of Dermatology and Syphilology"},{"key":"10.1002\/14651858.CD008394.pub2-BIB115|cit115","first-page":"1348","article-title":"Transfusion therapy","volume-title":"Emergency Medicine: A comprehensive study guide","author":"Santen","year":"2004"},{"issue":"5","key":"10.1002\/14651858.CD008394.pub2-BIB116|cit116","doi-asserted-by":"crossref","first-page":"197","DOI":"10.12968\/jowc.2007.16.5.27036","article-title":"Rapid healing of a late diagnosed sickle cell leg ulcer using a new combination of treatment methods","volume":"16","author":"Schleucher","year":"2007","journal-title":"Journal of Wound Care"},{"issue":"2","key":"10.1002\/14651858.CD008394.pub2-BIB117|cit117","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF01711070","article-title":"Microbial flora and its significance in pathology of sickle cell disease leg ulcers","volume":"20","author":"Sehgal","year":"1992","journal-title":"Infection"},{"issue":"1","key":"10.1002\/14651858.CD008394.pub2-BIB118|cit118","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/10641960802404078","article-title":"High prevalence of pulmonary hypertension in homozygous sickle cell patients with leg ulceration","volume":"31","author":"Serarslan","year":"2009","journal-title":"Clinical and Experimental Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD008394.pub2-BIB119|cit119","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.hoc.2005.08.005","article-title":"Leg ulceration in sickle cell disease: medieval medicine in a modern world","volume":"19","author":"Serjeant","year":"2005","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"5","key":"10.1002\/14651858.CD008394.pub2-BIB120|cit120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.2010.08419.x","article-title":"One hundred years of sickle cell disease","volume":"151","author":"Serjeant","year":"2010","journal-title":"British Journal of Haematology"},{"issue":"7","key":"10.1002\/14651858.CD008394.pub2-BIB121|cit121","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1182\/blood.V84.7.2378.2378","article-title":"Rapid healing of chronic leg ulcers during arginine butyrate therapy in patients\u00a0 with sickle cell disease and thalassemia","volume":"84","author":"Sher","year":"1994","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD008394.pub2-BIB122|cit122","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006214.pub3","article-title":"Debridement for surgical wounds","author":"Smith","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008394.pub2-BIB123|cit123","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00006534-198510000-00026","article-title":"The use of a free flap in homozygous sickle cell disease","volume":"76","author":"Spence","year":"1985","journal-title":"Plastic and Reconstructive Surgery"},{"key":"10.1002\/14651858.CD008394.pub2-BIB124|cit124","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1100\/tsw.2009.10","article-title":"Genetic etiologies for phenotypic diversity in sickle cell anemia","volume":"9","author":"Steinberg","year":"2009","journal-title":"Scientific World Journal"},{"key":"10.1002\/14651858.CD008394.pub2-BIB125|cit125","doi-asserted-by":"crossref","first-page":"e2095","DOI":"10.1371\/journal.pone.0002095","article-title":"Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasooclussive pain","volume":"3","author":"Taylor JG","year":"2008","journal-title":"PloSOne"},{"issue":"8","key":"10.1002\/14651858.CD008394.pub2-BIB126|cit126","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00129334-200410000-00010","article-title":"Leg ulcers in sickle cell disease","volume":"17","author":"Trent","year":"2004","journal-title":"Advances in Skin & Wound Care"},{"issue":"9","key":"10.1002\/14651858.CD008394.pub2-BIB127|cit127","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.puhe.2007.12.005","article-title":"Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies","volume":"122","author":"Tshilolo","year":"2008","journal-title":"Public Health"},{"issue":"1","key":"10.1002\/14651858.CD008394.pub2-BIB128|cit128","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003554.pub2","article-title":"Dressings and topical agents for surgical wounds healing by secondary intention","author":"Vermeulen","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008394.pub2-BIB129|cit129","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002106.pub3","article-title":"Dressings for superficial and partial thickness burns","author":"Wasiak","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008394.pub2-BIB130|cit130","article-title":"Inherited Disorders of Hemoglobin","volume-title":"Disease Control Priorities in Developing Countries","author":"Weatherall","year":"2006"},{"issue":"4","key":"10.1002\/14651858.CD008394.pub2-BIB131|cit131","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001273","article-title":"Oral zinc for arterial and venous leg ulcers","author":"Wilkinson","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD008394.pub2-BIB132|cit132","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.freeradbiomed.2008.01.008","article-title":"Sickle cell disease vasculopathy: a state of nitric oxide resistance","volume":"44","author":"Wood","year":"2008","journal-title":"Free Radical Biology and Medicine"}],"updated-by":[{"DOI":"10.1002\/14651858.cd008394.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T00:00:00Z","timestamp":1417996800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD008394.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T06:10:50Z","timestamp":1714543850000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008394.pub2"}},"subtitle":[],"editor":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,14]]},"references-count":132,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008394.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD008394.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2012,11,14]]}}}